Cassey D. Bauer

Array ( [id] => 8405467 [patent_doc_number] => 20120237526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'BACE1 INHIBITORY ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/377508 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11350 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7739490 [patent_doc_number] => 08105593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Anti-ADDL monoclonal antibody and use thereof' [patent_app_type] => utility [patent_app_number] => 12/793775 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 16336 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105593.pdf [firstpage_image] =>[orig_patent_app_number] => 12793775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007062 [patent_doc_number] => 20110059093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'USE OF AN ANTI-TAU PS422 ANTIBODY FOR THE TREATMENT OF BRAIN DISEASES' [patent_app_type] => utility [patent_app_number] => 12/792810 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16740 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059093.pdf [firstpage_image] =>[orig_patent_app_number] => 12792810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977713 [patent_doc_number] => 20110071088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'METHOD FOR TREATING NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/790515 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 31577 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071088.pdf [firstpage_image] =>[orig_patent_app_number] => 12790515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538446 [patent_doc_number] => 20100221746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 12/781196 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16920 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221746.pdf [firstpage_image] =>[orig_patent_app_number] => 12781196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262876 [patent_doc_number] => 20100297160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'High Molecular Weight Amyloid Beta As a Carrier for the Oral Delivery of Vaccine Antigens' [patent_app_type] => utility [patent_app_number] => 12/780628 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14931 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297160.pdf [firstpage_image] =>[orig_patent_app_number] => 12780628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232796 [patent_doc_number] => 08198234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Methods of suppressing microglial activation' [patent_app_type] => utility [patent_app_number] => 12/779725 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 13506 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198234.pdf [firstpage_image] =>[orig_patent_app_number] => 12779725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560393 [patent_doc_number] => 20100272648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Methods of Identifying Improved NMDA Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/772798 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31284 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272648.pdf [firstpage_image] =>[orig_patent_app_number] => 12772798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8955407 [patent_doc_number] => 08501177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Treatment of ectodermal dysplasia with EDA1 fusion proteins' [patent_app_type] => utility [patent_app_number] => 12/756268 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 29 [patent_no_of_words] => 12630 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9529743 [patent_doc_number] => 08753610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions' [patent_app_type] => utility [patent_app_number] => 12/756093 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 52 [patent_no_of_words] => 47324 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6135084 [patent_doc_number] => 20110008834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'POLYNUCLEOTIDES ENCODING ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/754579 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 41183 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008834.pdf [firstpage_image] =>[orig_patent_app_number] => 12754579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138565 [patent_doc_number] => 20120093832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS' [patent_app_type] => utility [patent_app_number] => 13/258714 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34152 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093832.pdf [firstpage_image] =>[orig_patent_app_number] => 13258714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8712840 [patent_doc_number] => 08398978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Antibodies directed against amyloid-beta peptide and methods using same' [patent_app_type] => utility [patent_app_number] => 12/724343 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29175 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12724343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059895 [patent_doc_number] => 08546330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Compositions and methods for treatment of neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 13/255244 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 37 [patent_no_of_words] => 15963 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425742 [patent_doc_number] => 20100151481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'CELL-SIGNALING ASSAYS' [patent_app_type] => utility [patent_app_number] => 12/713107 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11916 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151481.pdf [firstpage_image] =>[orig_patent_app_number] => 12713107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11218846 [patent_doc_number] => 09447175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Means and methods for manufacturing highly pure neurotoxin' [patent_app_type] => utility [patent_app_number] => 13/138452 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11798 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13138452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054109 [patent_doc_number] => 20120076785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'METHOD FOR INHIBITING NEURODEGENERATION' [patent_app_type] => utility [patent_app_number] => 13/202144 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 53850 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076785.pdf [firstpage_image] =>[orig_patent_app_number] => 13202144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6511549 [patent_doc_number] => 20100210818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'NUCLEIC ACIDS ENCODING THE HUMAN ALEX1 PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/706647 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28656 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210818.pdf [firstpage_image] =>[orig_patent_app_number] => 12706647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043195 [patent_doc_number] => 20120071337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHODS' [patent_app_type] => utility [patent_app_number] => 13/146121 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24846 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071337.pdf [firstpage_image] =>[orig_patent_app_number] => 13146121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7739493 [patent_doc_number] => 08105594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Methods for amyloid removal using anti-amyloid antibodies' [patent_app_type] => utility [patent_app_number] => 12/693085 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 7218 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105594.pdf [firstpage_image] =>[orig_patent_app_number] => 12693085 [rel_patent_id] =>[rel_patent_doc_number] =>)